REGENERON PHARMACEUTICALS, INC.: accounts_receivable

Value{"amount": 3111500000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2020-12-31)
Statussuperseded
EntityREGENERON PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001804220-21-000008
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000872589/accounts-receivable/2020-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/2ea28ccf-b113-4f87-a944-5c92e07ed257

History